Cancer Epigenetics Institute (CEI) Symposium 2026: From Fundamental Discovery to Therapeutic Impact

Reveal the power of the 6-base genome – Introducing duet multiomics solution evoC
5 March 2026
to 5 March 2026
8:30 am
to 7:30 pm
EST
The Franklin Institute
, Philadelphia
, United States of America

Visit biomodal at booth 

About the event

biomodal is proud to sponsor the Cancer Epigenetic Institute Symposium 2026!
Join us at our table to meet Craig Fishman, Steven Ciaramaglia and Mark Consugar and discover how biomodal’s groundbreaking multiomic technology illuminates the 6‑base genome—empowering researchers to unravel epigenetic complexity with unprecedented clarity.

The Fox Chase Cancer Center Cancer Epigenetics Institute (CEI) Symposium returns on Thursday, March 5, 2026 at the Franklin Institute in Philadelphia, Pennsylvania. This annual event will mark the 5th birthday of the CEI and include presentations from world-leaders from academia and industry on gene regulation to chromatin and 3D genome control to therapeutic opportunities.

Confirmed Keynotes:

  • Dr. Victor Ambros (Nobel Prize 2024; University of Massachusetts)
  • Dr. Kristian Helin (President & CEO, ICR, London)

Additional Confirmed World-Leaders:

  • Dr. Geeta Narlikar – University of California, San Francisco
  • Dr. Asifa Akhtar – Max Planck Institute of Immunobiology & Epigenetics
  • Dr. Rick Young – Massachusetts Institute of Technology
  • Dr. Charles Roberts – St. Jude Children’s Research Hospital
  • Dr. Suzanne Baker – St. June Children’s Research Hospital
  • Dr. Wolf Reik – Altos Labs

Official conference registration is here.

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Related resources

cfDNA fragmentomics: the next frontier in genetic testing

By analysing the unique fragmentation patterns of cfDNA, researchers are unlocking new possibilities for early disease detection, including cancer and prenatal testing. This cutting-edge field combines insights from epigenetics and nucleosome positioning to develop sensitive diagnostic tools that could transform healthcare.

Read more

Attending from biomodal

Mark Consugar

Mark Consugar

Associate Director of Scientific Affairs
Steven Ciaramaglia

Steven Ciaramaglia

US Territory Manager, Northeast

Register now

Meet our team at the event

CEI 2026 5MAR26
337325240511

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

What are you looking for?